Neck Pain, Pain, Neck
Conditions
Keywords
neck pain
Brief summary
The purpose of this randomized pragmatic clinical trial is to assess the effectiveness of the association of the osteopathic manipulative treatment in individuals with chronic non-specific neck pain who receive a exercice program and pain neurocience education.
Detailed description
The purpose of this study is to determine whether osteopathic manipulative treatment associated exercises and pain neurocience education improves pain and function in individuals with chronic non-specific neck pain Design: a randomized single blind controlled pragmatic trial will be conducted trial. Patients (n=40) with non-specific neck pain will be randomized to receive 1) osteopathic manipulative treatment and exercise and and pain neurocience education (n=20) or 2) exercise alone and pain neurocience education (n=20). Participants will receive 8 treatments during 4 weeks. Clinical outcomes will be obtained at 1 week, four weeks and 24 weeks after end of treatment. Methods: The primary outcome will be pain measured by 11-point numerical pain rating scale. The secondary outcome will be disability measured by the Neck Disability Index, range of motion measured by Cervical Range of Motion device, Pressure pain threshold measured by electronic algometer, global perceived effect, Pain Self-Efficacy Questionnaire and pain catastrophizing scale
Interventions
Exercise for stretching and strength for neck muscles and pain neuroscience education
Osteopathic manipulative treatment associated exercise for stretching and strength for neck muscles and pain neuroscience education
Sponsors
Study design
Eligibility
Inclusion criteria
* Symptoms of chronic neck pain does not specify that persists for more than 3 months * Pain at least 3 points on 0-10 numeric pain rating and at least 14% disability on Neck Disability Index
Exclusion criteria
* individuals who report inflammatory previous surgery, spondylolisthesis, spinal stenosis, herniated disc, radiculopathy, fracture and musculoskeletal degenerative diseases. , Cancer, neurological diseases, pregnancy. They will be excluded participants who received some form of manipulative treatment in the last three months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measured by numeric rating scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Functionality and disability | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measured by Neck Disability Scale |
| Range of motion | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measured by CROM device |
| Pressure pain threshold | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measured by electronic algometer |
| kinesiophobia | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measure by TAMPA scale |
| Self-efficacy | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measured by The Pain Self-Efficacy Questionnaire |
| Catastrophizing | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measure by pain catastrophizing scale |
| McGuill | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measure by Mcguill scale |
| Global perceived effect | Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment | measured by global perceived rating scale |
Countries
Brazil